See All Slides - tctmd.com

Slides

Presentation TCT 2012

Contrarian Position: Get Your Heads Out of the Sand! Genomics and Platelet Function Testing Will Revolutionize Tailored Antiplatelet Therapy!

Presenter: Matthew Price

October 24, 2012

Presentation TCT 2012

Two Illustrative Cases of Fistula Occlusion: One Uncomplicated, One Complex

Presenter: Christoph Nienaber

October 24, 2012

Presentation TCT 2012

Pro!(3)

Presenter: Duane Pinto

October 24, 2012

Presentation TCT 2012

A Fatal Retrograde Left Main Dissection

Presenter: Daniel Suerder

October 24, 2012

Presentation TCT 2012

JenaValve TAVR System

Presenter: Stephan Ensminger

October 24, 2012

Presentation TCT 2012

The Future of Surgical VADs

Presenter: William Cohn

October 24, 2012

Presentation TCT 2012

TIVUS (CardioSonic)

Presenter: Dierk Scheinert

October 24, 2012

Presentation TCT 2012

Impact of Completeness of Revascularization on Long-Term Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus: Results from the Bypass Angioplasty...

Presenter: Frederick Feit

October 24, 2012

Presentation TCT 2012

"Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting...

Presenter: Hyeon-Cheol Gwon

October 24, 2012

Presentation TCT 2012

TAVR in Japan and the United States

Presenter: Jodi Akin

October 24, 2012

Advertisement

Slides

Contrarian Position: Get Your Heads Out of the Sand! Genomics and Platelet Function Testing Will Revolutionize Tailored Antiplatelet Therapy!

Two Illustrative Cases of Fistula Occlusion: One Uncomplicated, One Complex

Pro!(3)

A Fatal Retrograde Left Main Dissection

JenaValve TAVR System

The Future of Surgical VADs

TIVUS (CardioSonic)

Impact of Completeness of Revascularization on Long-Term Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus: Results from the Bypass Angioplasty...

"Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting...

TAVR in Japan and the United States

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content